Very heavy on the buy side with share holders mostly holding firm.. Interesting trading activity nonetheless, if only their bids were 10 times higher..
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
